Initially funded by the Canceropôle PACA, the CRISPR screen platform enables genome-wide interrogation of the functional consequences of genomic or epigenomic alterations in coding and regulatory regions, revealing how genomic modifications lead to phenotypic changes.

Link: https://canceropole-paca.com/propulser-vos-recherches/crispr-screen-action-une-technologie-revolutionnaire-de-modification-du-genome/

Team Members:

Salvatore Spicuglia 
Iris Manosalva

External collaborators:

Sandrine Roulland – CIML, Marseille 
Bernard Mari – IPMC, Sophia-Antipolis 
Els Verhoeyen – C3M, Nice